When history can mislead a physician: a challenging case report of idiopathic pulmonary hemosiderosis—A case report and review of the literature Authors: Reem AlAgeel, Abdullah Aldraihem, Abdulmajeed Alfadhel, Khaled Aldraihem, Maha Sheikho, Anas Alturki, Tamer Abusido Published: 2026 ABSTRACT BackgroundIdiopathic pulmonary hemosiderosis is a rare condition characterized by non-immune-mediated alveolar hemorrhage. Its nonspecific clinical and radiological features make diagnosis particularly challenging. Idiopathic pulmonary hemosiderosis typically presents in older children with a classic triad of hemoptysis, chest X-ray abnormalities, and iron deficiency anemia. In contrast, preschool-aged children may show subtle signs such as respiratory distress, persistent cough, and pallor, which can mimic respiratory infections and lead to severe anemia. Prompt recognition is critical, as iron deposition in the alveoli adversely affects prognosis. Delayed diagnosis may result in pulmonary fibrosis, respiratory failure, or the need for lung transplantation.Case presentationWe report the case of a 3-year-old Asian girl with no significant medical history who presented with respiratory distress and severe anemia. She was initially treated as pneumonia with nutritional iron deficiency anemia, received a blood transfusion, and was discharged on iron and folic acid supplements; 2 weeks later, she returned with worsening respiratory distress, pallor, and hypoactivity. Workup revealed severe microcytic hypochromic anemia, elevated inflammatory markers, and bilateral heterogeneous opacities on chest X-ray. Diffuse alveolar hemorrhage was suspected and confirmed by bronchoscopy after exclusion of rheumatological diseases. Idiopathic pulmonary hemosiderosis was considered, and she was started on pulse methylprednisolone for 3 days, then weaned to maintenance prednisolone doses. Empirical antibiotics were discontinued after negative infectious studies. She showed significant clinical and radiological improvement within days, and at 2-month follow-up her hemoglobin was 11.2 g/dL.ConclusionThis case highlights the risk of misdiagnosing rare but serious conditions such as idiopathic pulmonary hemosiderosis. Early recognition and timely treatment are essential to improve outcomes and prevent long-term complications. Introduction Idiopathic pulmonary hemosiderosis (IPH) is a rare and often perplexing disorder that challenges clinicians because of its tendency to masquerade as more common conditions. IPH involves repeated episodes of bleeding into the alveoli, leading to the accumulation of hemosiderin, an iron‑rich pigment derived from hemoglobin. Although the exact cause of these hemorrhages remains unclear, the favorable response to corticosteroids and other immunosuppressive therapies suggests an autoimmune mechanism may play a role. IPH has also been linked to other conditions such as celiac disease and cow’s milk protein allergy, and familial cases have been reported, raising the possibility of genetic predisposition. While the true prevalence is unknown, most cases occur in children, typically before the age of 10 years. Prognosis varies widely, with survival ranging from just a few years to longer periods depending on the timeliness of diagnosis and treatment. Clinically, IPH can present in many ways—from dramatic episodes of hemoptysis to subtle signs such as chronic cough, pallor, or iron deficiency anemia. In children, recurrent respiratory distress and anemia are common, but the nonspecific nature of these symptoms often delays recognition. This underscores the importance of maintaining a high index of suspicion when evaluating pediatric patients with unexplained anemia and respiratory findings. Case presentation We cared for a 3‑year‑old girl of Asian descent who was born full‑term, unvaccinated, and had no significant past medical history. Her family history was unremarkable, with no inherited disorders or similar presentations. Her first admission to the pediatric intensive care unit (PICU) was prompted by severe respiratory distress. On examination, she was tachypneic, hypoxic, and markedly pale, with diffuse crackles heard across both lungs. Cardiac and abdominal exams were normal, and there were no dysmorphic features. Laboratory studies revealed profound microcytic hypochromic anemia, with hemoglobin at 3.4 g/dL. She was diagnosed with severe iron deficiency anemia alongside community‑acquired pneumonia (Fig. 1). After receiving a blood transfusion, she was discharged on iron and folic acid supplements.Fig. 1Chest X-ray showing bilateral patchy opacity mainly on the right side Chest X-ray showing bilateral patchy opacity mainly on the right side However, 2 weeks later she returned with worsening breathing difficulty, pallor, and hypoactivity. In the emergency department, she was stabilized with oxygen and started empirically on vancomycin and ceftazidime. Investigations showed hemoglobin at 5.4 g/dL, elevated white blood cell count, and high C-Reactive Protien (CRP) levels. Chest X‑ray revealed bilateral opacities (Fig. 2). She was transferred to the PICU, placed on nasal oxygen, and later required noninvasive ventilation. Another transfusion raised her hemoglobin to 8.4 g/dL.Fig. 2Second visit chest X-ray showing interval progression of bilateral diffuse airspace opacity Second visit chest X-ray showing interval progression of bilateral diffuse airspace opacity Given the recurrent anemia and concerning radiological findings, chest computed tomography (CT) was performed, showing patchy consolidation suggestive of alveolar hemorrhage (Fig. 3). IPH was suspected, and bronchoscopy was undertaken. Sequential bronchoalveolar lavage yielded progressively bloody fluid, confirming alveolar hemorrhage (Fig. 4). Cytology revealed hemosiderin‑laden macrophages, intact erythrocytes, and occasional neutrophils. All cultures were negative, leading to discontinuation of antibiotics.Fig. 3A Axial CT chest showing bilateral diffuse mosaic attenuation of the lungs with the presence of predominantly peripheral patchy ground glass opacities and consolidations with smooth interlobular septal thickening. B Coronal CT chest showing bilateral predominantly peripheral ground glass opacities with multifocal consolidation more in the lower lung zones and smooth interlobular septal thickeningFig. 4Bronchoalveolar lavage trap after multiple installations of normal saline and suction using a sequential technique, where it showed a final trap of bloody return A Axial CT chest showing bilateral diffuse mosaic attenuation of the lungs with the presence of predominantly peripheral patchy ground glass opacities and consolidations with smooth interlobular septal thickening. B Coronal CT chest showing bilateral predominantly peripheral ground glass opacities with multifocal consolidation more in the lower lung zones and smooth interlobular septal thickening Bronchoalveolar lavage trap after multiple installations of normal saline and suction using a sequential technique, where it showed a final trap of bloody return Further workup excluded rheumatological causes negative cytoplasmic antineutrophil cytoplasmic antibody (C‑ANCA) and anti‑glomerular basement membrane (GBM) antibodies, celiac disease (negative serology), and cow’s milk protein allergy (no gastrointestinal symptoms). Genetic testing and lung biopsy were discussed but deferred due to limited resources and the patient’s instability. With alternative diagnoses ruled out, IPH was considered the most likely explanation. She was treated with pulse methylprednisolone at 30 mg/kg/day for 3 days, followed by maintenance prednisolone at 1 mg/kg/day, along with iron and folic acid supplements. Her clinical and radiological status improved markedly (Fig. 5). At 2‑month follow‑up, she remained well, her hemoglobin had stabilized at 11.2 g/dL, and her imaging showed sustained improvement. Steroids were gradually tapered, and she continued to be monitored closely for relapse.Fig. 5Chest X-ray after therapy showing improvement of bilateral lung opacity Chest X-ray after therapy showing improvement of bilateral lung opacity Discussion Idiopathic pulmonary hemosiderosis (IPH), though rare, can be a life-threatening condition. It is defined by recurrent episodes of diffuse alveolar hemorrhage (DAH), which gradually lead to iron accumulation in the lungs. Most often, IPH affects children and young adults, and its nonspecific respiratory and hematologic features frequently delay diagnosis and treatment [1, 2]. The classic triad of hemoptysis, iron deficiency anemia, and diffuse pulmonary infiltrates is well recognized, but in younger children hemoptysis is often absent, making the diagnosis even more challenging [1]. In our case, the patient initially presented with severe anemia and respiratory distress, which was misinterpreted as pneumonia with nutritional anemia. Her rapid recurrence of symptoms and persistent anemia despite supplementation prompted further investigation. Bronchoscopy with bronchoalveolar lavage (BAL) was pivotal, revealing hemosiderin-laden macrophages, intact red blood cells, and occasional neutrophils findings that strongly supported DAH. Equally important was the exclusion of alternative causes such as celiac disease, cow’s milk protein allergy, and Goodpasture’s disease. This highlights the value of a thorough workup when IPH is suspected. While lung biopsy remains the gold standard for diagnosis, BAL findings combined with clinical presentation are often sufficient in pediatric patients, where invasive procedures carry greater risk [10]. The etiology of IPH remains uncertain, with hypotheses ranging from autoimmune and allergic mechanisms to genetic predisposition [3–6]. The favorable response to corticosteroids in our patient supports an immune-mediated process [4]. Although familial cases have been reported, no specific genetic mutations have been identified, and our patient’s negative family history made a hereditary cause less likely [6, 7]. Corticosteroids remain the cornerstone of therapy, aimed at suppressing inflammation and controlling bleeding [6, 11, 12]. Our patient responded well to pulse steroid therapy, with resolution of respiratory distress and stabilization of hemoglobin levels (Fig. 5). Adjunctive measures, including tranexamic acid nebulization and iron supplementation, further supported recovery. For patients with frequent relapses or steroid dependence, agents such as azathioprine or hydroxychloroquine may be considered. In severe refractory cases, plasmapheresis and immunosuppressive therapies such as cyclophosphamide or rituximab have been explored [6, 12, 13]. The prognosis of IPH is highly variable. Long-term survival is possible, particularly when diagnosis is made early and treatment is aggressive. However, recurrence is common, underscoring the need for vigilant long-term follow-up to detect relapses promptly and adjust therapy [10]. Conclusions This case emphasizes the importance of considering IPH in children with unexplained anemia and recurrent respiratory distress, especially when common infectious or hematologic causes have been excluded. Early recognition and timely initiation of immunosuppressive therapy can dramatically improve outcomes and survival. Bronchoscopy played a crucial role in establishing the diagnosis while ruling out infection. The patient’s stability during follow-up highlights the importance of close, long-term monitoring to detect relapses early and optimize therapy. Ultimately, this case reinforces the need for heightened clinical awareness of IPH, continued research into its underlying mechanisms, and exploration of genetic markers and targeted therapies to improve care for affected patients.